National Bank of Canada
ANIP icon

National Bank of Canada’s ANI Pharmaceuticals ANIP Stock Holding History

National Bank of Canada’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,177
Closed -$78.8K – 2984
2025
Q1 		$78.8K Buy
+1,177
New +$70.3K ﹤0.01% 1756

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

National Bank of Canada's ANIP Position: Q2 2025 in Review

National Bank of Canada sold out of ANI Pharmaceuticals (ANIP) in Q2 2025, closing a stake of 1,177 shares — an estimated $78.8K sold.

National Bank of Canada first reported a position in ANIP in Q1 2025 and held it in 1 quarter. The position peaked at $78.8K in Q1 2025. 232 funds tracked by Wall St. Rank hold ANIP as of Q2 2025.

  • National Bank of Canada reported no remaining ANI Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • National Bank of Canada sold 1,177 ANI Pharmaceuticals shares in Q2 2025, an estimated $78.8K.
  • National Bank of Canada first reported a position in ANI Pharmaceuticals in Q1 2025 and held it in 1 quarter.
  • National Bank of Canada's ANI Pharmaceuticals position peaked at $78.8K in Q1 2025.
  • 232 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2025.

Based on National Bank of Canada's 13F filing for Q2 2025, filed 13 Aug 2025.